Stevanato Group is the only company in Italy among the finalists in the running for the "Best new product award" in the European Outsourcing Awards 2009. The awards will take place in Madrid on the 14th of October, during the Convention on Pharmaceutical Ingredients. World leader in the production of pharmaceutical glass containers, the company has created the innovative product, EZ-FillTM  vials and cartridges.

The panel declared its product was one of the most promising in the category, confirming the Stevanato Group in its position as a market leader and one that has made product innovation one of its fundamental assets. The company invests more than 10 percent of its total turnover  in research and total turnover is expected reach more than  159 million euros in 2009.. 

EZ-FillTM  vials and cartridges broaden the range of EZ-FillTM  sterile products and will guarantee the supply of a ready-to-use, clean, sterile, apyrogen glass containers to pharmaceutical companies. "EZ-FillTM  vials and cartridges will provide added value for pharmaceutical companies - says Sergio Stevanato, CEO of Stevanato Group - They will then be able to outsource the first stage of the manufacturing process, reducing costs and concentrating their resources on research, which is their core business."

The company, which has demonstrated greater excellence in research and development than all the other finalists, in launching new products in the pharmaceutical and biopharmaceutical sector, and in the remarkable benefits from the use of its products compared to other therapies and products, seems certain to receive the Award.

"Being among the finalists of this important European Award, - says the President - is a further confirmation that our strategic choice to stress research and development has been a winner. Our firm not only produces glass containers for the pharmaceutical industry, but also machineries and technologies for their production. This gives us the possibility to constantly improve the performance of our products and introduce ongoing technical innovations."

It is the company's innovation that has made it the undisputed world leader and created its successful internationalization.  A total 70% of its production is exported abroad and it has generated orders from the world's largest pharmaceutical companies. Its growth is reflected in an increasing number of branches worldwide, with the latest in Monterrey, Mexico, opened to cater more effectively to the American pharmaceutical market.